They've actually developed two, Soberana 01 and 02. They're conducting 02 Phase 3 trials in partnership with Iran to assist with their struggle against COVID and because there aren't enough cases in Cuba for robust trials. Also two more at earlier phases, Mambisa and Abdala

— Rennis (@manamibadatmath) January 26, 2021